HOME > TOP STORIES
TOP STORIES
-
BUSINESS Around 140 Clinical Trials of Nucleic Acid Drugs Underway Worldwide, with Cancer, Neuropathy, and Myopathy as Main Targets
April 22, 2016
-
BUSINESS Japan’s 1st PCSK9 Inhibitor Hits Market; MHLW Issues Notification to Prevent Hasty Use
April 21, 2016
-
ACADEMIA AMED Study Team Drafting First Guidelines for Diagnosis and Treatment of Post-Stroke Epilepsy
April 21, 2016
-
ACADEMIA 17 Japanese Medical Societies Jointly Recommend HPV Vaccines
April 20, 2016
-
REGULATORY Sales Reps Top Source of Drug Safety Information for Both Clinics and Pharmacies: PMDA Survey
April 19, 2016
-
BUSINESS Wholesalers Say Drug Distributions in Quake-Hit Kumamoto More or Less Stable
April 19, 2016
-
BUSINESS Kaketsuken Halts Operations on April 18-20 after Quake
April 18, 2016
-
REGULATORY Promoting Use of Patient Registries Important in Building Clinical Innovation Network: Health Policy Bureau Chief
April 18, 2016
-
REGULATORY Expedited Review Systems Now in Place in 3 Major Markets, but How Are They Different?
April 15, 2016
-
REGULATORY Indication-Based Front-Loaded Re-Pricing, Coverage Limits Emerge for Pricey Meds: Chuikyo
April 14, 2016
-
REGULATORY Chuikyo OKs Repatha for NHI Price Listing on April 20, Peak Sales Projected at 49 Billion Yen
April 13, 2016
-
BUSINESS Ono Fires Back to 1.75 Trillion Yen Guesstimate, Puts Opdivo Sales at 126 Billion Yen
April 12, 2016
-
ORGANIZATION EFPIA Japan Chief to Call for “Real Dialogue” at Today’s Public-Private Policy Confab
April 12, 2016
-
REGULATORY With Eyes on Pricey Meds, Cost-Shaving Debate Unabated Despite Likely Tax Hike Delay
April 11, 2016
-
BUSINESS Kaketsuken in Talks to Transfer Vaccine Biz to Astellas
April 8, 2016
-
ORGANIZATION Front-Loaded Price Cuts Necessary for Drugs Like Opdivo: JMA’s Nakagawa
April 7, 2016
-
BUSINESS Mylan Japan Labor Union Raps Management over “Effective Dismissal”, No Progress Made in 1st Round of Negotiations
April 6, 2016
-
REGULATORY NCCHD Aims to Build “Million-Person Database” on Pediatric Patients; Could Lead to Improvements in Pharmacotherapy
April 6, 2016
-
REGULATORY MEXT to Set Up “Shared Facilities” for Drug Discovery, Push Open Innovation
April 5, 2016
-
BUSINESS Ex-Pfizer Japan Exec Matsumori to Lead Takeda-Teva JV
April 4, 2016
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
